A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center Trial of PBG-122 for the treatment of chicken pox in adult patients.
About the CPX Trial
MyMedCo is conducting the CPX Trial to determine effectiveness of the investigational medication pox-b-gone (also called PBG-122) as a treatment option for people with chicken pox. The CPX Trial will assess whether pox-b-gone eliminates the chicken pox outbreaks in patients.
The study has been reviewed and authorized by the FDA and is being conducted in the United States, Europe and Asia. For more information, please take a look at our Additional Information section below, visit clinicaltrials.gov or https://www.dontclickthisidkwhereitlinksto.com.
Trial Tech Medical 